AlphaStocks
6.5
Consider Buy

Encompass Health Corp (EHC)

As of Sep 20, 2026, Encompass Health Corp (EHC) scores 6.5/10 on AlphaStocks' five-model composite, #28 of 168 Health Care stocks. At $122, EHC trades 14% below its model fair value of $142.

Health Care / Health Care Facilities

S&P MidCap 400

$121.92

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#28out of 168 in Health Care

Is Encompass Health Corp a Good Investment in 2026?

Encompass Health Corp (EHC) scores 6.5 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Buffett model rates Encompass Health Corp as Attractive. However, the Lynch model rates it Caution — High PEG — growth premium · Slow Grower. Encompass Health Corp currently trades 14% below its estimated fair value of $142. Encompass Health Corp ranks #28 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E22.0ROE23.5Market Cap12BDiv Yield0.6

Estimated Fair Value

$142.3114% below

Trading below estimated fair value. EPS grew 24% year-over-year. ROE of 24% signals strong profitability. P/E of 22x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Limited Data

Financial health check (9 signals)

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Caution

High PEG — growth premium · Slow Grower

Greenblatt

Attractive

Earnings yield 6.8% · ROC 17%

Frequently Asked Questions

Is Encompass Health Corp (EHC) a good investment?
As of Sep 20, 2026, Encompass Health Corp (EHC) scores 6.5/10 on AlphaStocks' five-model composite, #28 of 168 Health Care stocks. At $122, EHC trades 14% below its model fair value of $142. That is a middle-of-the-pack score with no strong signal either way.
What is Encompass Health Corp's Piotroski F-Score?
Encompass Health Corp's Piotroski F-Score status is Limited Data. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is EHC overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $142, EHC appears undervalued. The stock currently trades 14% below its estimated fair value. Trading below estimated fair value. EPS grew 24% year-over-year. ROE of 24% signals strong profitability. P/E of 22x is moderate for this quality level.
How does EHC compare to other Health Care stocks?
Encompass Health Corp ranks #28 out of 168 stocks in the Health Care sector, placing it in the top 17% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about EHC?
AlphaStocks evaluates EHC using five proven investment models. Buffett: Attractive; Graham: Caution; Lynch: Caution; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 6.5/10.

Similar Stocks

THCUSPHUHS

Compare EHC with

EHC vs THCEHC vs USPHEHC vs UHS

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer